V. Hayden Thomas

589 total citations
11 papers, 326 citations indexed

About

V. Hayden Thomas is a scholar working on Pharmaceutical Science, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, V. Hayden Thomas has authored 11 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmaceutical Science, 3 papers in Pediatrics, Perinatology and Child Health and 2 papers in Infectious Diseases. Recurrent topics in V. Hayden Thomas's work include Drug Solubulity and Delivery Systems (4 papers), Synthesis and biological activity (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). V. Hayden Thomas is often cited by papers focused on Drug Solubulity and Delivery Systems (4 papers), Synthesis and biological activity (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). V. Hayden Thomas collaborates with scholars based in United States, Kuwait and India. V. Hayden Thomas's co-authors include D. Giles, Ayman El‐Kattan, Shobha Bhattachar, Narayanan Surendran, Chad Stoner, Amit Kumar Das, Yuriy A. Abramov, Takashi Mano, Elijah O. Kehinde and Mohsen A. Hedaya and has published in prestigious journals such as International Journal of Pharmaceutics, European Journal of Medicinal Chemistry and Drug Metabolism and Disposition.

In The Last Decade

V. Hayden Thomas

11 papers receiving 307 citations

Peers

Countries citing papers authored by V. Hayden Thomas

Since Specialization

Citations

This map shows the geographic impact of V. Hayden Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Hayden Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Hayden Thomas more than expected).

Fields of papers citing papers by V. Hayden Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Hayden Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Hayden Thomas. The network helps show where V. Hayden Thomas may publish in the future.

Co-authorship network of co-authors of V. Hayden Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of V. Hayden Thomas. A scholar is included among the top collaborators of V. Hayden Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Hayden Thomas. V. Hayden Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Coumarin Derivatives as Anti-inflammatory and Anticancer Agents 2017 ·Anti-Cancer Agents in Medicinal Chemistry ·V. Hayden Thomas, D. Giles, (unknown), Amit Kumar Das, (unknown)	47
2	Comparative Pharmacokinetic Study for Linezolid and Two Novel Antibacterial Oxazolidinone Derivatives in Rabbits: Can Differences in the Pharmacokinetic Properties Explain the Discrepancies between Their In Vivo and In Vitro Antibacterial Activities? 2017 ·Pharmaceutics ·Mohsen A. Hedaya, V. Hayden Thomas, Mohamed S. Abdel‐Hamid, Elijah O. Kehinde, Oludotun A. Phillips	8
3	A validated UPLC–MS/MS method for the analysis of linezolid and a novel oxazolidinone derivative (PH027) in plasma and its application to tissue distribution study in rabbits 2016 ·Journal of Chromatography B ·Mohsen A. Hedaya, V. Hayden Thomas, M. E. Abdel‐Hamid, Elijah O. Kehinde, Oludotun A. Phillips	13
4	Synthesis pharmacological evaluation and docking studies of pyrimidine derivatives 2012 ·European Journal of Medicinal Chemistry ·D. Giles, (unknown), (unknown), (unknown), (unknown), V. Hayden Thomas	58
5	Development of machine learning models of β-cyclodextrin and sulfobutylether-β-cyclodextrin complexation free energies 2011 ·International Journal of Pharmaceutics ·(unknown), Yuriy A. Abramov, (unknown), V. Hayden Thomas, Takashi Mano	26
6	Effect of chitosan glutamate, carbomer 974P, and EDTA on the in vitro Caco-2 permeability and oral pharmacokinetic profile of acyclovir in rats 2009 ·Drug Development and Industrial Pharmacy ·(unknown), Charles J. Rotter, Brian Rago, (unknown), Curt Christoffersen, V. Hayden Thomas, Matthew D. Troutman, Ayman El‐Kattan	18
7	Design and utilization of the drug–excipient chemical compatibility automated system 2008 ·International Journal of Pharmaceutics ·V. Hayden Thomas, (unknown)	16
8	Development of a semi-automated chemical stability system to analyze solution based formulations in support of discovery candidate selection 2006 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), V. Hayden Thomas	6
9	The road map to oral bioavailability: an industrial perspective 2006 ·Expert Opinion on Drug Metabolism & Toxicology ·V. Hayden Thomas, Shobha Bhattachar, (unknown), (unknown), (unknown), Narayanan Surendran, Chad Stoner, Ayman El‐Kattan	106
10	The Effect of Bergamottin on Diazepam Plasma Levels and P450 Enzymes in Beagle Dogs 2002 ·Drug Metabolism and Disposition ·Jasminder Sahi, Eric L. Reyner, Jonathan Bauman, (unknown), (unknown), V. Hayden Thomas	18
11	Antibacterial activity of marbofloxacin against bovine respiratory isolates 1997 ·H. Drugeon, V. Hayden Thomas, (unknown), (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact